Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 27, 2006Journal of Medicinal Chemistry

Medicinal Chemistry of Combretastatin A4:  Present and Future Directions

View Full Paper
Ask AI
Bookmark
Share

Authors

GTGian Cesare TronUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro”TPTracey PiraliUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro”GSGiovanni SorbaUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro”

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Tron et al. (2006) studied this question.

synapsesocial.com/papers/6a769dc5ec1fdabb7369a7e3https://doi.org/10.1021/jm0512903
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Synthesis and Structure−Activity Relationship of 2-Aminobenzophenone Derivatives as Antimitotic Agents2002 · 116 citations
  2. 2Phase I Trial of the Antivascular Agent Combretastatin A4 Phosphate on a 5-Day Schedule to Patients With Cancer: Magnetic Resonance Imaging Evidence for Altered Tumor Blood Flow2003 · 293 citations
  3. 3Tubulin as a target for anticancer drugs: Agents which interact with the mitotic spindle1998 · 647 citations